Moran Timothy P. 4

What Happened

• Timothy P. Moran, Chief Business Officer of Kestra Medical Technologies, acquired 227 shares on June 30, 2026 through the company’s 2025 Employee Stock Purchase Plan (ESPP). The reported purchase price was $21.55 per share for a total of about $4,892. This was a purchase (acquisition) rather than a sale.

Key Details

• Transaction date and price: 2026-06-30 — 227 shares at $21.55 each (total ~$4,892).
• Filing date: 2026-07-02; the Form 4 was filed promptly (not reported as late).
• Shares owned after transaction: Not specified in the filing (the form does not report total beneficial ownership here).
• Notable footnotes:
  • F1: Shares were purchased under the Kestra Medical 2025 ESPP and were exempt under Rule 16b-3.
  • F2: ESPP purchase price equaled 85% of Kestra’s closing stock price on June 29, 2026 (i.e., a 15% discount).
  • F3: Beneficial ownership counts on the filing, where present, include unvested RSUs.

Context

• ESPP purchases are routine employee benefit transactions that let employees buy company stock at a discount; they don’t necessarily indicate a change in insider sentiment but do represent an insider buying shares at a reduced price.
• This was a small-dollar acquisition (~$4.9k) by a C-suite officer and was executed via the company plan rather than an open-market purchase.